Upload
sudler-hennessey
View
56
Download
1
Tags:
Embed Size (px)
Citation preview
- Guidance for Industry: Presenting Risk Information in
Prescription Drug and Medical Device Promotion.
U.S. Department of Health and Human Services
Food and Drug Administration, May 2009
And the content will be designed to satisfy this FDA guidance:
“ ”
Responsive is table stakes
Rx sites now ~40% mobile traffic.
Any new sites clearly should be responsive.
THE SITUATION
MANY SIMILAR RESPONSIVE TEMPLATES(AGENCIES SEE LATEST APPROACHES FROM MANY CLIENTS)
WIDELY ADOPTED TECH PLATFORM(DRUPAL/ACQUIA IN PLACE AT MANY CLIENTS)
IDENTICAL LEGAL REQUIREMENTS
NO SECRETS(HTML/CSS/JS IS EXPOSED AT ANY Rx SITE LAUNCH)
OUR RECOMMENDATION
INDUSTRY-WIDE STANDARDS
FDA APPROVED
GOOGLE ALIGNED
PLATFORM OPTIMIZED
OPEN SOURCED
CORE INGREDIENTS
Persistent Fair Balance (locked, scrolling, expandable, integrated, search optimized)
Site Exit
window
Semantic templates for
Important Safety,
Prescribing Information,
Medication Guide
Professional Access
Gateway window
THE BENEFITS
CONSISTENCY OF USER EXPERIENCE
IMPROVE SEARCH RESULTS
CREATIVE & LEGAL CAN FOCUS ON BALANCE
WITHIN CONTENT AREAS
COST & TIME SAVINGS ON EVERY SITE
LEVERAGE Rx CODING COMMUNITY FOR
CLIENT SPECIFIC VERSIONS + UPDATES
NEXT STEPS
PUBLISH SITE STANDARDS
AS OPEN SOURCE (JUNE 2015)
EXTEND SITE TEMPLATES TO EX-U.S.
COUNTRY/REGION SPECIFIC VERSIONS
EXTEND Rx PROMO STANDARDS BEYOND
SITES:BANNERS, VIDEO, TABLET DETAILS, APPS
EXTEND DATA/SEMANTIC STANDARDS
Thanks!
Further information:
David Cherry
Chief Digital Officer
Sudler New York
212.614.4184